Global Circulating Tumor Cells Market Size & Outlook
Global circulating tumor cells market, 2021-2033 (US$M)
Related Markets
Global circulating tumor cells market highlights
- The global circulating tumor cells market generated a revenue of USD 14,041.4 million in 2025 and is expected to reach USD 38,954.0 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 13.9% by 2033.
- In terms of segment, ctc detection & enrichment methods accounted for a revenue of USD 7,918.3 million in 2025.
- CTC Analysis is the most lucrative technology segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, China is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 14,041.4 million |
| Market revenue in 2033 | USD 38,954.0 million |
| Growth rate | 13.9% (CAGR from 2026 to 2033) |
| Largest segment | Ctc detection & enrichment methods |
| Fastest growing segment | CTC Analysis |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CTC Detection & Enrichment Methods, CTC Direct Detection Methods, CTC Analysis |
Other key industry trends
- In terms of revenue, the North America accounted for 41.4% of the global circulating tumor cells market in 2025.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, China is the fastest growing regional market and is projected to reach USD 2,457.9 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Circulating Tumor Cells Market Scope
Circulating Tumor Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Vtex Ordinary Shares - Class A | View profile | 1277 | 125 Kingsway, Aviation House, London, United Kingdom, WC2B 6NH | https://www.vtex.com |
| Arcus Biosciences Inc | View profile | 577 | 3928 Point Eden Way, Hayward, CA, United States, 94545 | https://www.arcusbio.com |
| Neurocrine Biosciences Inc | View profile | 1448 | 12780 El Camino Real, San Diego, CA, United States, 92130 | https://www.neurocrine.com |
| Praxis Precision Medicines Inc Ordinary Shares | View profile | 82 | 99 High Street, 30th Floor, Boston, MA, United States, 02110 | https://www.praxismedicines.com |
| STEMCELL Technologies | View profile | 501-1000 | Vancouver, British Columbia, Canada, North America | https://www.stemcell.com |
| Menarini Group | View profile | 1001-5000 | Firenze, Toscana, Italy, Europe | http://www.menarini.com |
| Greiner Bio-One | View profile | 1001-5000 | Monroe, North Carolina, United States, North America | https://www.gbo.com/en_US/ |
| Ecolab Inc | View profile | 48000 | 1 Ecolab Place, Saint Paul, MN, United States, 55102 | https://www.ecolab.com |
| Aviva PLC | View profile | 23247 | St Helen's, 1 Undershaft, London, United Kingdom, EC3P 3DQ | https://www.aviva.com |
| Screen Holdings Co Ltd | View profile | 6589 | Tenjinkita-machi 1-1, Teranouchi-agaru, 4-chome, Horikawa-dori, Kamigyo-ku, Kyoto, Japan, 602-8585 | https://www.screen.co.jp |
| Miltenyi Biotec | View profile | 1001-5000 | Bergisch Gladbach, Nordrhein-Westfalen, Germany, Europe | http://www.miltenyibiotec.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Bio-Techne Corp | View profile | 3050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | https://www.bio-techne.com |
| Sysmex Corp | View profile | 10448 | 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 | http://www.sysmex.co.jp |
| Biocept Inc | View profile | 50 | 9955 Mesa Rim Road, San Diego, CA, United States, 92121 | https://www.biocept.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Epic Corp | View profile | 2 | PO Box 11147, Newport Beach, CA, United States, 92658 |
Global circulating tumor cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to circulating tumor cells market will help companies and investors design strategic landscapes.
Ctc detection & enrichment methods was the largest segment with a revenue share of 56.39% in 2025. Horizon Databook has segmented the Global circulating tumor cells market based on ctc detection & enrichment methods, ctc direct detection methods, ctc analysis covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Circulating Tumor Cells Technology Outlook (Revenue, USD Million, 2021-2033)
- CTC Detection & Enrichment Methods
- Combined Methods (Label-free)
- Size-based Separation (Label-free)
- Membrane-based
- Microfluidic-based
- Density-based Separation (Label-free)
- Immunocapture (Label-based)
- Positive Selection
- Negative Selection
- CTC Direct Detection Methods
- Microscopy
- Others
- SERS
- CTC Analysis
- CTC Detection & Enrichment Methods
- Global Circulating Tumor Cells Application Outlook (Revenue, USD Million, 2021-2033)
- Clinical/ Liquid Biopsy
- Risk Assessment
- Screening and Monitoring
- Research
- Cancer Stem Cell & Tumorogenesis Research
- Drug/Therapy Development
- Clinical/ Liquid Biopsy
- Global Circulating Tumor Cells Product Outlook (Revenue, USD Million, 2021-2033)
- Kits & Reagents
- Blood Collection Tubes
- Devices or Systems
- Global Circulating Tumor Cells Specimen Outlook (Revenue, USD Million, 2021-2033)
- Bone Marrow
- Other Body Fluids
- Blood
- Global Circulating Tumor Cells End Use Outlook (Revenue, USD Million, 2021-2033)
- Diagnostic centers
- Research and academic institutes
- Hospital and clinics
Reasons to subscribe to Global circulating tumor cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global circulating tumor cells market databook
-
Our clientele includes a mix of circulating tumor cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global circulating tumor cells market , including forecasts for subscribers. This global databook contains high-level insights into Global circulating tumor cells market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global circulating tumor cells market size, by regions, 2021-2033 (US$M)
Top 10 countries: Circulating tumor cells market size, 2025 (US$M)
Global circulating tumor cells market share, by technology, 2025 & 2033 (%, US$M)
Circulating tumor cells market: Opportunity assessment by country
Global circulating tumor cells market, by region, 2025 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
